Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r9data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

EpiKare Bio SA

History from 19 Aug 2025

UID
CHE-353.951.823
Legal form
AG
Canton
VD
Founded
19 Aug 2025
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 116k
29k58k87k116k7 Oct 2026 · CHF 116k
  • shares

Record

  1. SHAB published 27 Aug 2025 · legal date 19 Aug 2025

    Company formed

    Founded 19 Aug 2025

    SHAB HR01-1006418311 ↗

  2. SHAB published 7 Oct 2026 · legal date 25 Aug 2026

    Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    104’000 → 116’000
    Shares
    — → 116’000
    New shares, % of post-step shares
    — (share counts not published)
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.72 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006776960 ↗

  3. SHAB published 7 Oct 2026 · legal date 25 Aug 2026

    Capital band adopted

    SHAB HR02-1006776960 ↗

Published by 8 Oct 2026